Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

The tumor microenvironment (TME) in ovarian cancer (OC) is characterized by immune suppression, due to an abundance of suppressive immune cells populations. To effectively enhance the activity of immune checkpoint inhibition (ICI), there is a need to identify agents that target these immunosuppressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavicic, Paul G., Rayman, Patricia A., Swaidani, Shadi, Rupani, Amit, Makarov, Vladimir, Tannenbaum, Charles S., Edwards, Robert P., Vlad, Anda M., Diaz-Montero, C. Marcela, Mahdi, Haider
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101660/
https://www.ncbi.nlm.nih.gov/pubmed/37066116
http://dx.doi.org/10.1080/2162402X.2023.2198185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101660/
https://www.ncbi.nlm.nih.gov/pubmed/37066116
http://dx.doi.org/10.1080/2162402X.2023.2198185

Ejemplares similares